| Prev Close | 138.10 |
| Day Low/High | 136.86 / 138.39 |
| 52 Wk Low/High | 118.62 / 148.99 |
| Avg Volume | 7.52M |
Johnson & Johnson (JNJ)
136.91
NYSE : Health Technology
| Exchange | NYSE |
| Shares Outstanding | 2.66B |
| Market Cap | 367.73B |
| EPS | 5.70 |
| P/E Ratio | 24.62 |
| Div & Yield | 3.60 (2.62%) |
Cramer: Goldman's Downgrade Of J&J Is 'Questionable'
Johnson & Johnson had a very good acquisition
Johnson & Johnson Is Getting Ready for Another Upside Breakout
A cover shorts signal was triggered, and an outright go long signal could follow soon.
Cramer: Got the Apple-FANG Blues? Look for a Rotation
There's one going on now.
Johnson & Johnson, 3M and 8 Other Winners From the Ridiculously Weaker Dollar
U.S. companies that have significant sales in Europe are about to reap the benefits of a weak greenback.
Cramer: There Should Be More Takeovers Where These Came From
Buying's good for the acquirers, which should give other companies ideas.
Cramer: Ready for the New Normal? Here It Is
Problem areas such as the dollar, oil and retail move to the foreground.
How EY's Kerrie MacPherson Uses Decades of Experience to Help a New Generation of Women Win
EY's Kerrie MacPherson Wants To Pave the Way for future female entrepreneurs.
How JNJ's Chief Medical Officer Fell In Love With Science -- In a Bakery
JNJ's Chief Medical Officer fell in love with science after spending so much time in her family's bakery
My Takeaways and Observations
"I wanted a perfect ending. Now I've learned, the hard way, that some poems don't rhyme, and some stories don't have a clear beginning, middle, and end. Life is about not knowing, having to change, taking the moment and making the best of it, withou...
President Trump Outlines Plans for Fighting in Afghanistan
President Donald Trump said troop levels will be ramped up but no numbers were given.
Cramer: How Picking Stocks Is Like Fantasy Football
Hear me out: The same lessons and disciplines are useful in both.
Don't Get Out of Joint
Demand for artificial joints is growing, and Zimmer Biomet is a good way to play the demographic trend.
CEOs Dump Donald Trump
CEOs exit President's Council after Charlottesville response
Chart Signals End to Dollar Trend
The dollar index is now in an area of strong support.
My Takeaways and Observations (Early Edition)
The story's in the past with nothin' to recall, I've got my life to live and I don't need you at all. The roller-coaster ride we took is nearly at an end, I bought my ticket with my tears, that's all I'm gonna spend. -- The Cyrkle, Red Rubber Ball M...
Here's What Up (and Down)
After 90 minutes of trading here are some market features: * Bonds are getting schmeissed. The 10-year U.S. note yield is close to 2.32% and the long bond is knocking on the door of 3.00%. A possible equity market headwind. * Retail still has a ni...
Biotech Sees Sharp Reversal
Biotech, as represented by iShares Nasdaq Biotechnology Index Fund , universally beloved by technicians and "talking heads" has just suffered an abrupt intraday turnaround. There may be a lesson here -- that charts often tell us where stocks have be...
My Takeaways and Observations (Early Afternoon Edition)
"Keep the juices flowin' by janglin' round gently as you move." -- Jonathan Heller, Catch The Wisdom As of 2PM a most quiet and uneventful day. (Famous Last Words!) "Takeaways" is out early because I have a handful of earnings reports I wanted t...
Cramer: Rotations Hit Companies That Don't Deserve It
Case in point: Home Depot and Lowe's.
Cramer: We Need a Vaccine for Washington
It's difficult for even the best companies to resist infection.
Some Lunchtime Reading
As we head into the lunch hour, here's some reading that I think/hope you'll enjoy: Brian Sozzi shares some views on what Costco (COST) can do to thwart Amazon . "I think Costco will be just fine as it opens more warehouse locations, although they s...
Jim Cramer on Netflix, Bank of America, Goldman Sachs, UnitedHealth, Johnson & Johnson, Advanced Micro Devices, IBM and Nvidia
TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer weighs in on Tuesday's trending stocks.
It's Report Week: Keep an Eye on the Big Companies
It's Report Week: Keep an Eye on the Big Companies
We're Seeing Earnings Beat, but Then There Is Trump
Bulletproof coffee in hand, a quick scan of the markets shows the futures up ever so slightly as investors grapple with the realization the GOP is giving up on replacing the Affordable Care Act and is turning to repealing it. That news is pressuring...
Now Up to the Plate, Today's Pinch Hitter, Chris Versace!
Here we go folks -- another day, another diary. Today I, Chris Versace, once again am sitting in for Doug. It's going to be an action-packed day, with a smattering of earnings from Bank of America , Goldman Sachs , Johnson & Johnson and more than a ...
Healthcare Earnings on Tap; Measuring the Force of Amazon
As always, it was good seeing everyone on the Daily Diary sitting in for Doug Kass. Lots of good conversation despite a quiet day in the market with the market indices ending the day pretty much where they started. Very narrow range of trading throu...
Cramer: This Week of Earnings Will Tell Us Just About Everything We Need to Know
Procter & Gamble proxy fight is an intriguing distraction.
Cramer: 10 Reasons for Today's Rally
Days like this remind you why you stay in.
Nasdaq Shows Signs of Weakness
While the Dow is trading sideways, Nasdaq downtrend may already have started.
Second Half Favors the 'Little Guys'
The market is telling us that the easy money in large-cap names has already been made.
